BioAge Labs, Inc. (BIOA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$7.05−$0.1600 (−2.22%) on the dayAs of the close; data may be delayed.
BIOA price, last 12 months
Key stats
- Previous close
- $7.21
- Open
- $7.26
- Day range
- $7.03 – $7.30
- 52-week range
- $5.04 – $25.96
- Volume
- 630.3K
- Avg volume (20 days)
- 694.1K
- Market cap
- $323.6M
Performance
1W−12.5%
1M−28.4%
3M−70.3%
6M−56.6%
YTD−46.7%
1Y+32.8%
vs S&P 500, 1Y+16.0 pts
Technicals and fundamentals
About BioAge Labs, Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $323.6M